Following the disclosure of these financial figures, the company’s management team will host a conference call on Thursday, August 20, 2026, from 15:30 to 16:30 HKT. The session will feature prepared remarks regarding the firm’s performance, followed by an open question-and-answer period.

The leadership panel includes Chairman Lior Moshe Dayan, CEO Eyal Ben David, Co-CEO and CFO Jiahong Li, and Investor Relations Director Hui Fan. Stakeholders may attend via teleconference or webcast, with live interpretation provided in both English and Chinese. Participants are required to register in advance through the company’s designated portal. A digital replay will be archived on the Sisram Medical investor relations website shortly after the call concludes.